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SUMMARY 
A young manic patient who showed poor response to lithium, neuroleptics and ECT and devclcped 
severe cxtrapyrami<lal side effects restricting the use of neuroleptics in high doses ; showed marked cli-
nical improvement with a combination of carbamazepine and lithium with sustained recovery. The case 
reported to illustrate the possible synergistic action suggested earlier, encouraging the authors to take up 
a crossover trial. 
While lithium salts arc efficacious in 
manic states 20% are nonresponders. 
Amongst various therapeutic advances 
which have occurej, carbamazepine seems 
promising (Pou, 1982). Further, when 
used in combination, carbamazepine and 
lithium seem to function synergistically 
(Lipinski & Pope, 1982). VVc had an 
opportunity to tty this combination, in 
a manic patient who responded inade-
quately to lithium carbonate. 
CASE REPORT 
Ms. J, an 18 yrs. old female patient 
with a family history of affective illness 
was admitted in August 1982 with clinical 
piciuie of acute manic excitement, with 
history of three manic epi-odes earlier 
between 197C and 1980. She was treated 
with Haloperidol (15 mgs/day) and lith-
ium carbonate (1200 mgs/day) orally 
and was discharged 2 weeks later follo-
wing clinical improvement. However, 
she was readmitted within 3 weeks in 
September, 1932 with a relapse in her 
clinical condition, though the family 
claimed full thug compliance. With 
Haloperidol (20 mgs/day) and lithium 
carbonate (1200 mgs/day) she had to be 
given 4 modified bilateral EGTs. She 
showed clinical improvement and was 
discharged six weeks later. 
Within 3 weeks again, the patient 
had to be readmitted in acute manic 
excitement. Serum lithium estimation 
was carried out to ascertain the drug 
compliance which indicated that the 
compliance had been adequate. After 
admission, the patient showed no im-
provement with chlorpromazine (600 mgs/ 
day) and lithium carbonate (1509 mgs/ 
day). 
Since the patient had iiot responded 
adequately to lithium carbonate as evi-
denced by rapid relapses and the persis-
tent manic feitures despite adequate 
serum levels (between 0.7 to 1.4 mEq/L) 
foi sufficient length of time (14 weeks) 
alternative management was consideied 
and all the drugs were stopped. She 
was started on carbamazepine 600 mgs/ 
day orally in divided doses. After one 
week, the clinical features remained sta-
tic. Lithium carbonate (1500 mgs/day) 
was reintroduced along with carbamaze-
pine (600 mgs/day). Within one week, 
marked clinical improvement was evident 
and the patient has been on regular 
follow-up as an out-patient. For 3 
months she has not relapsed and main-
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tains complc.e recovery on lithium carbo-
nate (1500 mgs/day) and Carbamazepine 
(400 mgs/day;. 
COMMENT 
Our patient was treated with Lithium 
Carbonate and neuroleptics during the 
first two admissions. The improvement 
on each occassion occurcd after a long 
interval; 3 weeks on the first occassion 
and 6 weeks during the second admission, 
during which EGTs became necessary 
to obtain better results. Afier discharge, 
the improvement was sustained for a 
very short period (3 weeks) on bo'h the 
occasions deipite regular medication. 
During the second admission the patient 
had developed severe drug induced extra-
pyramidal side-effects restricting the use 
of neuroleptics in high do.es. During 
the third admission, while the patient 
did not show any response to carbamaze-
pine alone, with a combination of carba-
mazepine and lithium she showed marked 
improvemen* within ore week. This 
improvement has been well maintained 
over a period of next 3 months. Thus, 
it suppo.ts the earlier report (Lipir.ski 
& Pope, 1982) of a possible synergistic 
action for this efficacy. Because a single 
c isc doe^ not fully substantiate the routine 
clinical use of this combination when 
needed, we are at pre ent evaluating the 
efficacy of this combination in a clinical 
crossover trial. 
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